newsfilter
← Latest News
GlobeNewswire·

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

JUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic," "we," "us," "our," or the "Company") (NASDAQ:DYAI), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the